References
- Moertel C G, Sauer W G, Dockerty M B, Baggenstoss A H. Life history of the carcinoid tumour of the small intestine. Cancer 1961; 14: 901–12
- Cheek R C, Wilson H. Carcinoid tumours. Curr Probl Surg 1970; 4: 31–4
- Davis Z, Moertel C G, McIlrath D C. The malignant carcinoid syndrome. Surg Gynecol Obstet 1973; 137: 637–44
- Kvols L K, Moertel C G, O'Connell M J, Schutt A J, Rubin J, Hahn R G. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663–6
- Öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumours with human leucocyte interferon. Cancer Treat Rep 1986; 70: 1297–304
- Hanssen L E, Schrumpf E, Kolbenstvedt A N, Tausjö J, Dolva LÖ. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human 2b interferon with or without prior hepatic artery embolisation. Scand J Gastroenterol 1989; 24: 787–95
- Chayvialle J A. Sandostatin and carcinoid tumours in France: Experience in the Lyon area. Digestion 1990; 45(Suppl 1)23–6
- Ahlman H, Wängberg B, Jansson S, et al. Management of disseminated midgut carcinoid tumours. Digestion 1991; 49: 78–96
- Geterud K, Tylén U, Jansson S, Stenqvist O, Tisell L-E, Ahlman H. Hepatic arterial embolisation of the treatment of the midgut carcinoid syndrome and other advanced endocrine tumours metastatic to the liver. J Intervent Radiol 1990; 5: 69–76
- Cho K J, Reuter S R, Schmidt R. Effects of experimental hepatic artery embolisation on hepatic function. AJR 1976; 27: 563–7
- Chuang V P, Wallace S. Hepatic artery embolisation in the treatment of hepatic neoplasms. Radiology 1981; 140: 51–8
- Lunderquist A, Ericsson M, Nobin A, Sandén G. Gel foam powder embolisation of the hepatic artery in liver metastases of carcinoid tumours. Radiologe 1982; 22: 65–70
- Allison D J, Modlin I M, Jenkins W J. Treatment of carcinoid liver metastases by hepatic artery embolization. Lancet 1977; 2: 1323–5
- Pueyo I, Jimenez J R, Hernandez J, et al. Carcinoid syndrome treated by hepatic embolization. AJR 1978; 131: 511–3
- Mitry H A, Warner R RP, Newman L H, Trains J S, Parnes I H. Control of carcinoid syndrome with hepatic artery embolisation. Radiology 1985; 155: 623–6
- Carrasco C H, Charnsangavej C, Ajani J, Samaan N A, Richli W, Wallace S. The carcinoid syndrome. Palliation by hepatic artery embolisation. AJR 1986; 147: 149–54
- Coupe M O, Hodgson H JF, Hemingway A. Allison DJ. The effect of hepatic artery embolisation on survival in the carcinoid syndrome. J Intervent Radiol 1989; 4: 179–181
- Bengmark S, Rosengren K. Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am J Surg 1970; 119: 620–4
- Rosenberg S A, Packard B S, Aebersold P M, et al. Use of tumour-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 1988; 319: 1676–80
- Sa Rosenberg, Aebersold P M, Cornetta K, et al. Gene transfer in human immunotherapy of patients with advanced melanoma, using tumour-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990; 323: 570–8
- Roodman G D, Kurihara N, Ohsaki Y, et al. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 1992; 89: 46–51